Myoendothelial Junction and Microparticle Stimulation of PAH Vascular Lesions
Myoendothelial Junction and Microparticle Stimulation of PAH Vascular Lesions
批准号:
8335472
负责人:
Natalie Norwood Bauer
金额:
$7.43万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-23 至 2014-07-31
关键词:
AffectApoptosisApoptoticArterial DisorderBioenergeticsBiological MarkersBlood VesselsCaliberCell ProliferationCellsCoculture TechniquesCommunicationDataDevelopmentDiseaseDisease ProgressionEndothelin-1EndotheliumExhibitsFunctional disorderGap JunctionsHomeostasisHypoxiaInflammationInjuryLesionLipidsLungMaintenanceMembrane ProteinsMessenger RNAMicroRNAsModelingMolecularOutcomeParentsPathogenesisPatientsPhenotypeProcessPropertyProteinsPulmonary artery structurePulmonary vesselsRattusResistanceRoleSerotoninSeveritiesSignal TransductionSignaling MoleculeSmooth Muscle MyocytesSystemTestingTherapeuticVascular DiseasesVascular Smooth MuscleVesicleangiogenesisarterial lesionarteriolebasehemodynamicsimprovedinsightmonolayernovelnovel therapeuticsparacrinepulmonary arterial hypertension
中文摘要
摘要
英文摘要
ABSTRACT
The molecular mechanisms underlying formation of occlusive vascular lesions in pulmonary
arterial hypertension (PAH) are unknown. PASMCs in the normal vasculature exhibit a
differentiated, contractile, non-proliferative phenotype. During the development of PAH, the
PASMCs dedifferentiate and become hyperproliferative and migratory leading to neointimal
occlusion of small pulmonary arteries and arterioles. Although several signaling molecules have
been investigated, it remains unclear what the vascular signals are that cause this
dedifferentiation and neointimal lesion formation. Crosstalk between PAECs and PASMCs has
long been suspected to participate in pathogenesis of PAH. Further, our data suggest direct
interactions between PAECs and PASMCs through myoendothelial gap junctions are important
for maintenance of the normal differentiated PASMC phenotype. Injury or alterations to the
PAEC monolayer affect the differentiation status of the adjoining PASMCs. Not only do
PASMCs and PAECs communicate with each other, but PAECs are also exposed to numerous
circulating factors. Microparticles (MPs) are circulating intact vesicles which function as
regulators of vascular homeostasis, cell proliferation, and angiogenesis; all vital processes in
PAH occlusive vascular lesion formation. Based on these observations this proposal tests the
overall hypothesis that aberrant myoendothelial gap junctional signaling between PAECs and
PASMCs contributes to the arteriopathy of PAH by promoting dedifferentiation and proliferation
of PASMCs, and that MPs from PAH patients participate in the pathogenesis of the vascular
disease by inducing PAEC dysfunction and disrupting the gap junctional signaling. Specific
Aims test the hypotheses that: Aim 1: Aberrant gap junctional signaling between PAH
PAECs and PASMCs promotes PASMC dedifferentiation and proliferation. Aim 2: Circulating
MPs isolated from PAH patients cause PAEC dysfunction and disrupt myoendothelial gap
junctional signaling, which leads to dedifferentiation and proliferation of co-cultured PASMCs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Circulating microparticle effects on phenotypically distinct pulmonary endothelium
-
批准号:9256870
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2017
-
负责人:Natalie Norwood Bauer
-
依托单位:
Myoendothelial Junction and Microparticle Stimulation of PAH Vascular Lesions
-
批准号:8211913
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Natalie Norwood Bauer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: